# Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.

> **NCT06920329** · NA · NOT_YET_RECRUITING · sponsor: **Xiamen Hospital of Traditional Chinese Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** Peginterferon α-2b based injection

## Key facts

- **NCT ID:** NCT06920329
- **Lead sponsor:** Xiamen Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920329, "Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06920329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*